Macrophages and tissue injury: Agents of defense or destruction?

Annual Review of Pharmacology and Toxicology

Volumn 51, Issue , 2011, Pages 267-288

  Laskin, Debra L ^a   Sunil, Vasanthi R ^a   Gardner, Carol R ^a   Laskin, Jeffrey D ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

cytokines; fibrosis; inflammation; liver; lung; RNS; ROS

Indexed keywords

1,2 DICHLOROBENZENE; ALCOHOL; ASBESTOS; BLEOMYCIN; CADMIUM; CARBON TETRACHLORIDE; CHEMOKINE; CYTOKINE; ENDOTOXIN; GALACTOSAMINE; LIPID; OZONE; PARACETAMOL; PHENOBARBITAL; PROTEINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; THIOACETAMIDE;

ARTICLE; EXHAUST GAS; FIBROSIS; HUMAN; HYPEROXIA; INFECTION; INFLAMMATION; LIVER TOXICITY; LUNG ALVEOLUS MACROPHAGE; LUNG TOXICITY; MACROPHAGE; NEOPLASM; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; RADIATION INJURY; TARGET ORGAN; TISSUE INJURY; WOUND HEALING;

ANIMALS; FIBROSIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; NEOPLASMS; WOUND HEALING; XENOBIOTICS;

EID: 79951963634     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.010909.105812     Document Type: Article

References (186)

1. Metchnikoff E. 1968. Lectures on the Comparative Pathology of Inflammation Delivered at the Pasteur Institute in 1891. New York: Dover
2. Zhang X, Mosser DM. 2008. Macrophage activation by endogenous danger signals. J. Pathol. 214:161-78 (Pubitemid 351160154)
3. Holt MP, Cheng L, Ju C. 2008. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J. Leukoc. Biol. 84:1410-21 (Pubitemid 352774476)
4. Trujillo G, O'Connor EC, Kunkel SL, Hogaboam CM. 2008. A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 172:1209-21 (Pubitemid 351671535)
5. Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front. Biosci. 13:453-61 (Pubitemid 351599757)
6. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL. 2002. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093-103 (Pubitemid 34454006)
7. Laskin DL. 2009. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem. Res. Toxicol. 22:1376-85
8. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al. 2005. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142:481-89 (Pubitemid 41719844)
9. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-69
10. Stout RD, Suttles J. 2004. Functional plasticity of macrophages: reversible adaptation to changing mi-croenvironments. J. Leukoc. Biol. 76:509-13 (Pubitemid 39129080)
11. Laskin DL, Gardner CR. 2007. Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity. In Drug-Induced Liver Disease, ed. N Kaplowitz, LD DeLeve, pp. 159-84. New York: Informa Healthcare. 2nd ed.
12. Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang X-J, et al. 1998. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 26:748-54 (Pubitemid 28103551)
13. Laskin DL, Pilaro AM. 1986. Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol. Appl. Pharmacol. 86:204-15 (Pubitemid 17190053)
14. Orfila C, Lepert JC, Alric L, Carrera G, Beraud M, et al. 1999. Expression of TNF-α and immunohis-tochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. Histochem. J. 31:677-85
15. Laskin DL, Robertson FM, Pilaro AM, Laskin JD. 1988. Activation of liver macrophages following phenobarbital treatment of rats. Hepatology 8:1051-55
16. +-galactosamine hepatotoxicity. Br. J. Exp. Pathol. 68:189-99 (Pubitemid 17051485)
17. Pilaro AM, Laskin DL. 1986. Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharide treatment of rats. J. Leukoc. Biol. 40:29-41 (Pubitemid 16067612)
18. McCloskey TW, Todaro JA, Laskin DL. 1992. Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology 16:191-203
19. Lloyd SA, Franklin MR. 1991. Modulation of carbon tetrachloride hepatotoxicity and xenobiotic-metabolizing enzymes by corticosterone pretreatment, adrenalectomy and sham surgery. Toxicol. Lett. 55:65-75
20. Madhu C, Maziasz T, Klaassen CD. 1992. Effect of pregnenolone-16 α-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 115:191-98
21. Laskin DL, Gardner CR, Price VF, Jollow DJ. 1995. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21:1045-50
22. Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. 1999. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30:186-95 (Pubitemid 29300585)
23. Muriel P, Alba N, Perez-Alvarez VM, Shibayama M, Tsutsumi VK. 2001. Kupffer cell inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 130:219-26 (Pubitemid 32905300)
24. Muriel P, Escobar Y. 2003. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachlo-ride. J. Appl. Toxicol. 23:103-8 (Pubitemid 36417111)
25. Abdel-Zaher AO, Abdel-Rahman MM, Hafez MM, Omran FM. 2007. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage. Toxicology 234:124-34 (Pubitemid 46517830)
26. Goldin RD, Ratnayaka ID, Breach CS, Brown IN, Wickramasinghe SN. 1996. Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity. J. Pathol. 179:432-35 (Pubitemid 26276115)
27. Przybocki JM, Reuhl KR, Thurman RG, Kauffman FC. 1992. Involvement of nonparenchymal cells in oxygen-dependent hepatic injury by allyl alcohol. Toxicol. Appl. Pharmacol. 115:57-63
28. Iimuro Y, Yamamoto M, Kohno H, Itakura J, Fujii H, Matsumoto Y. 1994. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats-analysis of mechanisms of lethality in endotoxemia. J. Leukoc. Biol. 55:723-28 (Pubitemid 24207401)
29. Ishiyama H, Ogino K, Hobara T. 1995. Role of Kupffer cells in rat liver injury induced by diethyldithio-carbamate. Eur. J. Pharmacol. 292:135-41
30. Koop DR, Klopfenstein B, Iimuro Y, Thurman RG. 1997. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol. Pharmacol. 51:944-50 (Pubitemid 27249127)
31. Harstad EB, Klaassen CD. 2002. Gadolinium chloride pretreatment prevents cadmium chloride-induced liver damage in both wild-type and MT-null mice. Toxicol. Appl. Pharmacol. 180:178-85 (Pubitemid 34526458)
32. Andres D, Sanchez-Reus I, Bautista M, Cascales M. 2003. Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity: expression of metallothionein and HSP70. Biochem. Pharmacol. 66:917-26 (Pubitemid 37083588)
33. Al-Tuwaijri A, Akdamar K, Di Luzio NR. 1981. Modification of galactosamine-induced liver injury in rats by reticuloendothelial system stimulation or depression. Hepatology 1:107-13 (Pubitemid 11055067)
34. Kalabis GM, Wells PG. 1990. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid. J. Pharmacol. Exp. Ther. 255:1408-19
35. Maddox JF, Amuzie CJ, Li M, Newport SW, Sparkenbaugh E, et al. 2010. Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity. J. Toxicol. Environ. Health A 73:58-73
36. Masubuchi Y, Sugiyama S, Horie T. 2009. Th1/Th2 cytokine balance as a determinant of acetaminophen-induced liver injury. Chem. Biol. Interact. 179:273-79
37. Gardner CR, Laskin JD, Dambach DM, Sacco M, Durham SK, et al. 2002. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-α and interleukin-10. Toxicol. Appl. Pharmacol. 184:27-36 (Pubitemid 35264668)
38. Dambach DM, Durham SK, Laskin JD, Laskin DL. 2006. Distinct roles of NF-κB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol. Appl. Pharmacol. 211:157-65 (Pubitemid 43238309)
39. Pritchard MT, Cohen JI, Roychowdhury S, Pratt BT, Nagy LE. 2010. Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J. Hepatol. 53:655-62
40. Morio LA, Chiu H, Sprowles KA, Zhou P, Heck DE, et al. 2001. Distinct roles of tumor necrosis factor-α and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol. Appl. Pharmacol. 172:44-51 (Pubitemid 32281410)
41. Vollmar B, Ruttinger D, Wanner GA, Leiderer R, Menger MD. 1996. Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock 6:434-41 (Pubitemid 126727786)
42. Hatano M, Sasaki S, Ohata S, Shiratsuchi Y, Yamazaki T, et al. 2008. Effects of Kupffer cell-depletion on concanavalin A-induced hepatitis. Cell. Immunol. 251:25-30
43. + monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50:261-74
44. Gardner CR, Laskin JD, Dambach DM, Chiu H, Durham SK, et al. 2003. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1: potential role of inflammatory mediators. Toxicol. Appl. Pharmacol. 192:119-30 (Pubitemid 37194516)
45. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Evanoff HL, et al. 2000. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164:2738-44 (Pubitemid 30115507)
46. Yee SB, Bourdi M, Masson MJ, Pohl LR. 2007. Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease. Chem. Res. Toxicol. 20:734-44 (Pubitemid 46953680)
47. Laskin DL, Chen L, Hankey PA, Laskin JD. 2010. Role of STK in mouse liver macrophage and en-dothelial cell responsiveness during acute endotoxemia. J. Leukoc. Biol. 88:373-82
48. Liu Y, Gardner CR, Laskin JD, Laskin DL. 2010. Classical and alternative activation of rat liver Kupffer and endothelial cells: impact of acetaminophen (APAP). The Toxicologist 114:158 (Abstr.)
49. Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, et al. 2002. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem. Res. Toxicol. 15:1504-13 (Pubitemid 36008198)
50. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, et al. 2002. Protection against acetaminophen-induced liver injury and lethality byinterleukin 10: role of inducible nitric oxide synthase. Hepatology 35:289-98 (Pubitemid 34106367)
51. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, et al. 1998. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28:1607-15 (Pubitemid 28549131)
52. Donahower B, McCullough SS, Kurten R, Lamps LW, Simpson P, et al. 2006. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G102-9 (Pubitemid 44024667)
53. Hogaboam CM, Bone-Larson CL, Steinhauser ML, Matsukawa A, Gosling J, et al. 2000. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am. J. Pathol. 156:1245-52 (Pubitemid 30660003)
54. Heymann F, TrautweinC, TackeF. 2009. Monocytes and macrophages ascellular targetsinliver fibrosis. Inflamm. Allergy Drug Targets 8:307-18
55. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, et al. 2009. CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185-97
56. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, et al. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Investig. 115:56-65 (Pubitemid 40385505)
57. Laskin DL, Weinberger B, Laskin JD. 2001. Functional heterogeneity in liver and lung macrophages. J. Leukoc. Biol. 70:163-70 (Pubitemid 32751506)
58. Tsushima K, King LS, Aggarwal NR, De Gorordo A, D'Alessio FR, Kubo K. 2009. Acute lung injury review. Intern. Med. 48:621-30
59. Fakhrzadeh L, Laskin JD, Laskin DL. 2002. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am. J. Respir. Cell Mol. Biol. 26:413-19 (Pubitemid 34253925)
60. Pendino KJ, Meidhof TM, Heck DE, Laskin JD, Laskin DL. 1995. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am. J. Respir. Cell Mol. Biol. 13:125-32
61. Pendino KJ, Laskin JD, Shuler RL, Punjabi CJ, Laskin DL. 1993. Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase. J. Immunol. 151:7196-205 (Pubitemid 24001094)
62. Pendino KJ, Gardner CR, Shuler RL, Laskin JD, Durham SK, et al. 1996. Inhibition of ozone-induced nitric oxide synthase expression in the lung by endotoxin. Am. J. Respir. Cell Mol. Biol. 14:516-25 (Pubitemid 126442943)
63. Fakhrzadeh L, Laskin JD, Gardner CR, Laskin DL. 2004. Superoxide dismutase-overexpressing mice are resistant to ozone-induced tissue injury and increases in nitric oxide and tumor necrosis factor-α. Am. J. Respir. Cell Mol. Biol. 30:280-87 (Pubitemid 38315380)
64. Fakhrzadeh L, Laskin JD, Laskin DL. 2004. Ozone-induced production of nitric oxide and TNF-αand tissue injury are dependent on NF-κB p50. Am. J. Physiol. Lung Cell. Mol. Physiol. 287:L279-85 (Pubitemid 38943910)
65. Tasat DR, Mancuso R, Evelson P, Polo JM, Llesuy S, Molinari B. 2002. Radiation effects on oxidative metabolism in young and aged rat alveolar macrophages. Cell. Mol. Biol. 48:529-35
66. Inghilleri S, Morbini P, Oggionni T, Barni S, Fenoglio C. 2006. In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem. Cell Biol. 125:661-69 (Pubitemid 43785960)
67. Johnston CJ, Williams JP, Elder A, Hernady E, Finkelstein JN. 2004. Inflammatory cell recruitment following thoracic irradiation. Exp. Lung Res. 30:369-82 (Pubitemid 38925124)
68. Pendino KJ, Shuler RL, Laskin JD, Laskin DL. 1994. Enhanced production of interleukin-1, tumor necrosis factor-α, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11:279-86
69. Malaviya R, Sunil VR, Cervelli J, Anderson DR, Holmes WW, et al. 2010. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol. Appl. Pharmacol. 248:89-99
70. Wigenstam E, Rocksen D, Ekstrand-Hammarstrom B, Bucht A. 2009. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal. Toxicol. 21:958-64
71. Haddad EB, Liu SF, Salmon M, Robichaud A, Barnes PJ, Chung KF. 1995. Expression of inducible nitric oxide synthase mRNA in Brown Norway rats exposed to ozone: effect of dexamethasone. Eur. J. Pharmacol. 293:287-90
72. DiMatteo M, Reasor MJ. 1997. Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol. Appl. Pharmacol. 142:411-21 (Pubitemid 28381032)
73. Chen F, Gong L, Zhang L, Wang H, Qi X, et al. 2006. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur. J. Pharmacol. 536:287-95
74. Giri SN, Benson J, Siegel DM, Rice SA, Schiedt M. 1975. Effects of pretreatment with anti-inflammatory drugs on ozone-induced lung damage in rats. Proc. Soc. Exp. Biol. Med. 150:810-14
75. Bhalla DK, Daniels DS, Luu NT. 1992. Attenuation of ozone-induced airway permeability in rats by pretreatment with cyclophosphamide, FPL 55712, and indomethacin. Am. J. Respir. Cell Mol. Biol. 7:73-80
76. Elder AC, Gelein R, Oberdorster G, Finkelstein J, Notter R, Wang Z. 2004. Efficient depletion of alveolar macrophages using intratracheally inhaled aerosols of liposome-encapsulated clodronate. Exp. Lung Res. 30:105-20 (Pubitemid 38293712)
77. Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young HA, Aizawa H. 2009. Role of proinflammatory cytokines IL-18 and IL-1β in bleomycin-induced lung injury in humans and mice. Am. J. Respir. Cell Mol. Biol. 41:661-70
78. Hashimoto N, Kawabe T, Imaizumi K, Hara T, Okamoto M, et al. 2004. CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 30:808-15 (Pubitemid 38736904)
79. Okuma T, Terasaki Y, Sakashita N, Kaikita K, Kobayashi H, et al. 2006. MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production. Int. J. Exp. Pathol. 87:475-83 (Pubitemid 44813866)
80. Chyczewska E, Chyczewski L, Bankowski E, Sulkowski S, Niklinski J. 1993. Stimulation of alveolar macrophagesbyBCG vaccine enhances the processoflungfibrosis inducedbybleomycin.Folia Histochem. Cytobiol. 31:113-16
81. Tasaka S, Ishizaka A, Urano T, Sayama K, Sakamaki F, et al. 1995. BCG priming enhances endotoxin-induced acute lung injury independent of neutrophils. Am. J. Respir. Crit. Care Med. 152:1041-49
82. Gordon S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35 (Pubitemid 37328697)
83. Hamilton RF Jr, Thakur SA, Mayfair JK, Holian A. 2006. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J. Biol. Chem. 281:34218-26 (Pubitemid 46036630)
84. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, et al. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. USA 105:9035-40
85. Kuhlmann UC, Chwieralski CE, Van Den Brule S, Rocken C, Reinhold D, et al. 2009. Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases. Life Sci. 84:1-11
86. Murray LA, Rosada R, Moreira AP, Joshi A, Kramer MS, et al. 2010. Serum amyloid P therapeuti-cally attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One 5:e9683
87. Buttner C, Skupin A, Reimann T, Rieber EP, Unteregger G, et al. 1997. Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am. J. Respir. Cell Mol. Biol. 17:315-25 (Pubitemid 127500836)
88. Misson P, Van Den Brule S, Barbarin V, Lison D, Huaux F. 2004. Markers of macrophage differentiation in experimental silicosis. J. Leukoc. Biol. 76:926-32 (Pubitemid 39458704)
89. Migliaccio CT, Buford MC, Jessop F, Holian A. 2008. The IL-4Rα pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. J. Leukoc. Biol. 83:630-39 (Pubitemid 351966873)
90. Hancock A, Armstrong L, Gama R, Millar A. 1998. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am. J. Respir. Cell Mol. Biol. 18:60-65 (Pubitemid 128355347)
91. Barbarin V, Xing Z, Delos M, Lison D, Huaux F. 2005. Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L841-48 (Pubitemid 40547909)
92. 1. J. Exp. Med. 194:809-21 (Pubitemid 32983016)
93. Okuma T, Terasaki Y, Kaikita K, Kobayashi H, Kuziel WA, et al. 2004. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J. Pathol. 204:594-604 (Pubitemid 39585959)
94. Inoshima I, Kuwano K, Hamada N, Hagimoto N, Yoshimi M, et al. 2004. Anti-monocyte chemoattrac-tant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L1038-44 (Pubitemid 38508815)
95. HesseM,Cheever AW, Jankovic D,Wynn TA. 2000. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am. J. Pathol. 157:945-55 (Pubitemid 32109386)
96. Arthur MJP, Bentley IS, Tanner AR, Saunders PK, Millward-Sadler GH, Wright R. 1985. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology 89:1114-22 (Pubitemid 16231579)
97. 4. Inflamm. Res. 49:700-7 (Pubitemid 32097086)
98. Elsisi AE, Hall P, Sim WL, Earnest DL, Sipes IG. 1993. Characterization of vitamin A potentiation of carbon tetrachloride-induced liver injury. Toxicol. Appl. Pharmacol. 119:280-88 (Pubitemid 23122839)
99. Hendriks HF, Horan MA, Durham SK, Earnest DL, Brouwer A, et al. 1987. Endotoxin-induced liver injury in aged and subacutely hypervitaminotic A rats. Mech. Ageing Dev. 41:241-50 (Pubitemid 18015554)
100. Guanawardhana L, Mobley SA, Sipes IG. 1993. Modulation of 1,2-dichlorobenzene hepatotoxicity in the Fischer-344 rat by a scavenger of superoxide anions and an inhibitor of Kupffer cells. Toxicol. Appl. Pharmacol. 119:205-13 (Pubitemid 23122830)
101. Rahman I, Massaro D. 1992. Endotoxin treatment protects rats against ozone-induced lung edema: with evidence for the role of manganese superoxide dismutase. Toxicol. Appl. Pharmacol. 113:13-18
102. Tsan MF, Lee CY, White JE. 1991. Interleukin 1 protects rats against oxygen toxicity. J. Appl. Physiol. 71:688-97
103. Mikawa K, Nishina K, Maekawa N, Obara H. 1995. Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: effects on inflammatory mediators. Acta Anaesthesiol. Scand. 39:317-22
104. Nakae D, Yamamoto K, Yoshiji H, Kinugasa T, Maruyama H, et al. 1990. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am. J. Pathol. 136:787-95 (Pubitemid 20142315)
105. Shiratori Y, Kawase T, Shiina S, Okano K, Sugimoto T, et al. 1988. Modulation of hepatotoxicity by macrophages in the liver. Hepatology 8:815-21
106. Nakahira K, Takahashi T, Shimizu H, Maeshima K, Uehara K, et al. 2003. Protective role of heme oxygenase-1 induction in carbon tetrachloride-induced hepatotoxicity. Biochem. Pharmacol. 66:1091-105 (Pubitemid 37083606)
107. Rabbani ZN, Anscher MS, Folz RJ, Archer E, Huang H, et al. 2005. Overexpression of extracellular superoxide dismutase reduces acute radiation-induced lung toxicity. BMC Cancer 5:59-71
108. Laskin JD, Heck DE, Laskin DL. 2009. Nitric oxide pathways in toxic responses. In General and Applied Toxicology, ed. B Ballantyne, T Marrs, T Syversen, pp. 425-38. Hoboken, NJ: Wiley
109. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. 2006. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80:1298-307 (Pubitemid 44904968)
110. Yeh DY, Feng NH, Chen CF, Lin HI, Wang D. 2008. Inducible nitric oxide synthase expressions in different lung injury models and the protective effect of aminoguanidine. Transplant. Proc. 40:2178-81
111. Genovese T, Cuzzocrea S, Di Paola R, Failla M, Mazzon E, et al. 2005. Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury. Respir. Res. 6:58
112. Nozaki Y, Hasegawa Y, Takeuchi A, Fan ZH, Isobe KI, et al. 1997. Nitric oxide as an inflammatory mediator of radiation pneumonitis in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 272:L651-58
113. Becher R, Bucht A, Ovrevik J, Hongslo JK, Dahlman HJ, et al. 2007. Involvement of NADPH oxidase and iNOS in rodent pulmonary cytokine responses to urban air and mineral particles. Inhal. Toxicol. 19:645-55 (Pubitemid 46788946)
114. Venkatraman A, Shiva S, Wigley A, Ulasova E, Chhieng D, et al. 2004. The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 40:565-73 (Pubitemid 39265577)
115. Zeidler P, Hubbs A, Battelli L, Castranova V. 2004. Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis. J. Toxicol. Environ. Health A 67:1001-26 (Pubitemid 38822691)
116. Owen CA. 2008. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int. J. Chronic Obstr. Pulm. Dis. 3:253-68 (Pubitemid 352037885)
117. Adamson IY, Vincent R, Bakowska J. 2003. Differential production of metalloproteinases after instilling various urban air particle samples to rat lung. Exp. Lung Res. 29:375-88 (Pubitemid 36999989)
118. Tanner A, Keyhani A, Reiner R, Holdstock G, Wright R. 1981. Proteolytic enzymes released by liver macrophages may promote injury in a rat model of hepatic damage. Gastroenterology 80:647-54 (Pubitemid 11137741)
119. Yan C, Zhou L, Han YP. 2008. Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure. Liver Int. 28:959-71 (Pubitemid 352044444)
120. Park SY, Shin HW, Lee KB, Lee MJ, Jang JJ. 2010. Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury. J. Korean Med. Sci. 25:570-76
121. Anderson DR, Taylor SL, Fetterer DP, Holmes WW. 2009. Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology 263:41-46
122. Guignabert C, Taysse L, Calvet JH, Planus E, Delamanche S, et al. 2005. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L67-74 (Pubitemid 40863556)
123. Suzuki T, Chow CW, Downey GP. 2008. Role of innate immune cells and their products in lung immunopathology. Int. J. Biochem. Cell Biol. 40:1348-61
124. Kuhn DC, Griffith JW, Stauffer JL, Riling S, Demers LM. 1993. Characterization of alveolar macrophage eicosanoid production in a non-human primate model of mineral dust exposure. Prostaglandins 46:207-20 (Pubitemid 23286112)
125. 2 from macrophages of rats with silicosis. Am. J. Respir. Cell Mol. Biol. 6:390-96
126. Luckey SW, Petersen DR. 2001. Activation of Kupffer cells during the course of carbon tetrachloride- induced liver injury and fibrosis in rats. Exp. Mol. Pathol. 71:226-40 (Pubitemid 34060097)
127. Gardner CR, Gray JP, Joseph LB, Cervelli J, Bremer N, et al. 2010. Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 245:36-46
128. Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, et al. 2001. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 14:1620-28 (Pubitemid 34016626)
129. Begay CK, Gandolfi AJ. 2003. Late administration of COX-2 inhibitors minimize hepatic necrosis in chloroform-induced liver injury. Toxicology 185:79-87 (Pubitemid 36050732)
130. Horrillo R, Planaguma A, Gonzalez-Periz A, Ferre N, Titos E, et al. 2007. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor. J. Pharmacol. Exp. Ther. 323:778-86 (Pubitemid 350146060)
131. Nakano H, Aizawa H, Matsumoto K, Fukuyama S, Inoue H, Hara N. 2000. Cyclooxygenase-2 participates in the late phase of airway hyperresponsiveness after ozone exposure in guinea pigs. Eur. J. Pharmacol. 403:267-75
132. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK. 1985. The relation of leukotrienes to liver injury. Hepatology 5:883-91 (Pubitemid 15236639)
133. Montuschi P. 2008. Leukotrienes, antileukotrienes and asthma. Mini Rev. Med. Chem. 8:647-56
134. Titos E, Claria J, Planaguma A, Lopez-Parra M, Gonzalez-Periz A, et al. 2005. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells. J. Leukoc. Biol. 78:871-78 (Pubitemid 41384403)
135. Shimbori C, Shiota N, Okunishi H. 2010. Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice. Exp. Lung Res. 36:292-301
136. Shiratori Y, Tanaka M, Umihara J, Kawase T, Shiina S, Sugimoto T. 1990. Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide- activated macrophages. J. Hepatol. 10:51-61 (Pubitemid 20006989)
137. Ishizaka A, Hasegawa N, Sakamaki F, Tasaka S, Nakamura H, et al. 1994. Effects of ONO-1078, a peptide leukotriene antagonist, on endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 150:1325-31
138. 4 receptor antagonist SC-53228 on ozone-induced airway hyperresponsiveness and inflammation in dogs. Am. J. Respir. Crit. Care Med. 152:1443-48
139. Failla M, Genovese T, Mazzon E, Gili E, Muia C, et al. 2006. Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Respir. Res. 7:137
140. Karidis NP, Kouraklis G, Theocharis SE. 2006. Platelet-activating factor in liver injury: a relational scope. World J. Gastroenterol. 12:3695-706 (Pubitemid 43950947)
141. Yost CC, Weyrich AS, Zimmerman GA. 2010. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie 92:692-97
142. Gardner CR, Laskin JD, Laskin DL. 1993. Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells. J. Leukoc. Biol. 53:190-96 (Pubitemid 23100163)
143. Kaneko T, Ikeda H, Fu L, Nishiyama H, Okubo T. 1995. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs. Eur. J. Pharmacol. 292:251-55
144. Tan WC, Bethel RA. 1992. The effect of platelet activating factor antagonist on ozone-induced airway inflammation and bronchial hyperresponsiveness in guinea pigs. Am. Rev. Respir. Dis. 146:916-22
145. Pendino KJ, Gardner CR, Laskin JD, Laskin DL. 1993. Induction of functionally active platelet-activating factor receptors in rat alveolar macrophages. J. Biol. Chem. 268:19165-68 (Pubitemid 23270679)
146. Rabinovici R, Esser KM, Lysko PG, Yue TL, Griswold DE, et al. 1991. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ. Res. 69:12-25
147. Yue TL, Farhat M, Rabinovici R, Perera PY, Vogel SN, Feuerstein G. 1990. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. J. Pharmacol. Exp. Ther. 254:976-81 (Pubitemid 20303729)
148. 4-induced liver cirrhosis. World J. Gastroenterol. 12:709-15 (Pubitemid 43380752)
149. Bradley JR. 2008. TNF-mediated inflammatory disease. J. Pathol. 214:149-60 (Pubitemid 351160153)
150. Mukhopadhyay S, Hoidal JR, Mukherjee TK. 2006. Role of TNFα in pulmonary pathophysiology. Respir. Res. 7:125
151. Chiu H, Gardner CR, Dambach DM, Durham SK, Brittingham JA, et al. 2003. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol. Appl. Pharmacol. 193:218-27 (Pubitemid 37476437)
152. Chiu H, Gardner CR, Dambach DM, Brittingham JA, Durham SK, et al. 2003. Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am. J. Physiol. Gastrointest. Liver Physiol. 285:G959-66 (Pubitemid 37310075)
153. Hishinuma I, Nagakawa J, Hirota K, Miyamoto K, Tsukidate K, et al. 1990. Involvement of tumor necrosis factor-αin development of hepatic injury in galactosamine-sensitized mice. Hepatology 12:1187-91
154. Kayama F, Yoshida T, Elwell MR, Luster MI. 1995. Role of tumor necrosis factor-αincadmium-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 131:224-34
155. Perkins RC, Scheule RK, Hamilton R, Gomes G, Freidman G, Holian A. 1993. Human alveolar macrophage cytokine releasein response to invitro and invivo asbestos exposure. Exp. Lung Res. 19:55-65 (Pubitemid 23042788)
156. Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN. 1993. Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150:4188-96 (Pubitemid 23129800)
157. Fakhrzadeh L, Laskin JD, Laskin DL. 2008. Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-α following ozone inhalation. Toxicol. Appl. Pharmacol. 227:380-89
158. Czaja MJ, Xu J, Alt E. 1995. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108:1849-54
159. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-63 (Pubitemid 19226654)
160. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. 1990. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245-47
161. KruglovAA, Kuchmiy A, Grivennikov SI, Tumanov AV, Kuprash DV, Nedospasov SA. 2008. Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models. Cytokine Growth Factor Rev. 19:231-44
162. Zhang M, Qian J, Xing X, Kong FM, Zhao L, et al. 2008. Inhibition of the tumor necrosis factor-a pathway is radioprotective for the lung. Clin. Cancer Res. 14:1868-76 (Pubitemid 351469474)
163. Gasse P, Mary C, Guenon I, Noulin N, Charron S, et al. 2007. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Investig. 117:3786-99 (Pubitemid 350224089)
164. Churg A, Zhou S, Wang X, Wang R, Wright JL. 2009. The role of interleukin-113 in murine cigarette smoke-induced emphysema and small airway remodeling. Am. J. Respir. CellMol. Biol. 40:482-90
165. Bless NM, Huber-Lang M, Guo RF, Warner RL, Schmal H, et al. 2000. Role of CC chemokines (macrophage inflammatory protein-113, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J. Immunol. 164:2650-59 (Pubitemid 30115497)
166. Bhatia M, Brady M, Zagorski J, Christmas SE, Campbell F, et al. 2000. Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 47:838-44
167. Duffield JS. 2003. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. 104:27-38 (Pubitemid 36249921)
168. Benoit M, Desnues B, Mege JL. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181:3733-39
169. Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8:349-61 (Pubitemid 351595216)
170. Scher JU, Pillinger MH. 2005. 15d-PGJ2: the anti-inflammatory prostaglandin? Clin. Immunol. 114:100-9
171. Zingarelli B, CookJA. 2005. Peroxisome proliferator-activated receptor-y is a new therapeutic target in sepsis and inflammation. Shock 23:393-99 (Pubitemid 40571660)
172. Chiang N, Arita M, Serhan CN. 2005. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 73:163-77 (Pubitemid 41253473)
173. Levy BD. 2005. Lipoxins and lipoxin analogs in asthma. Prostaglandins Leukot. Essent. Fatty Acids 73:231-37 (Pubitemid 41253480)
174. Serhan CN, Chiang N 2008. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153(Suppl. 1):S200-15 (Pubitemid 351340979)
175. Gonzalez-Periz A, Planaguma A, Gronert K, Miquel R, Lopez-Parra M, et al. 2006. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D 1 and 17S-hydroxy-DHA. FASEBJ. 20:2537-39
176. Gowdy K, Krantz QT, Daniels M, Linak WP, Jaspers I, Gilmour MI. 2008. Modulation of pulmonary inflammatory responses and antimicrobial defenses in mice exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 229:310-19
177. Bhandari V, Choo-WingR, Homer RJ, EliasJA. 2007. Increased hyperoxia-induced mortality and acute lung injury in IL-13 null mice. J. Immunol. 178:4993-5000 (Pubitemid 46595282)
178. Hocke AC, Ermert M, Althoff A, Brell B, NGuessan PD, et al. 2006. Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs: comparison of the constitutive expression between rats and humans. Cytokine 33:199-211
179. Pulichino AM, Wang IM, Caron A, Mortimer J, Auger A, et al. 2008. Identification of transforming growth factor α31-driven genetic programs of acute lung fibrosis. Am. J. Respir. CellMol. Biol. 39:324-36
180. Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, et al. 2000. Dose-dependent induction of transforming growth factor α3 (TGF-13) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 47:1033-42 (Pubitemid 30345604)
181. 3) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions. J. Comp. Pathol. 133:92-102 (Pubitemid 41150166)
182. 4-induced liver fibrosis. J. Appl. Toxicol. 28:1021-26
183. Barbarin V, Arras M, Misson P, Delos M, McGarry B, et al. 2004. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 31:78-85 (Pubitemid 38888042)
184. Chen LC, Gordon RE, Laskin JD, Laskin DL. 2007. Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Exp. Mol. Pathol. 83:311-26 (Pubitemid 350087034)
185. Zhang X, Yu WP, Gao L, Wei KB, Ju JL, Xu JZ. 2004. Effects of lipopolysaccharides stimulated Kupffer cells on activation of rat hepatic stellate cells. World J. Gastroenterol. 10:610-13 (Pubitemid 38325326)
186. Nishimura Y, Nishiike-Wada T, Wada Y, Miura Y, Otsuki T, Iguchi H. 2007. Long-lasting production of TGF-β1 by alveolar macrophages exposed to low doses of asbestos without apoptosis. Int. J. Immunopathol. Pharmacol. 20:661-71